Cover Image

Economic Impact assessment on Good Pharmacy Practice Regulation in Thai Community Pharmacy

Thatjuta Wuttipanich, Tanattha Kitisopee

Abstract


Good Pharmacy Practice (GPP) in community and hospital pharmacy setting is a crucial standard for pharmacy services. The Thai Food and Drug Administration (Thai-FDA) realized the benefit of GPP and tried to implement this concept as a regulation for every community pharmacy. As a result, the Ministerial Regulation on Application and Issuance of License to Modern Pharmacies was implemented, so the new community pharmacies which open after the issue of this regulation must abide by it if they open after 26th June 2014. However, the Thai- FDA gave a period within eight years for old pharmacies to adapt to this new regulation. Thus, this study aimed to explore the economic impact in terms of cost-benefit of the Ministerial Regulation on Application and Issuance of License to Modern Pharmacies. This regulation was revised to improve the quality and standard of community pharmacies. The data was obtained from self-administered questionnaires sent to Type I pharmacy owners, excluding the accredited pharmacies, and from the published literature and expert opinion. This study was performed from a societal perspective. The result showed that the total 8-year cost was $1,317.90 million dollars (48,639.61 million baht) and total 8-year benefit was $3,672.34 million dollars (136,027.69 million baht). NPV and benefit to cost ratio were $ 2,087.79 million dollars (68,458.75 million baht) and 2.79 benefit: cost, respectively. The one-way best case and worse case sensitivity result presented that the net benefit ranged from -$856.14 million dollars to $20,815.45 million dollars (– 28,072.91 to 682,538.71 million baht). Cost of pharmacy closing down was the least sensitive variable in this model. Cost of Drug-Related problem (DRP) per case and number of DRPs in community pharmacies were the important factors which might contribute to an impact on net benefit. The implementation of this regulation seems to have provided positive financial return on investment to Thai society.

Full Text:

110-118:PDF

References


World Health Organization. Joint FIP/WHO Guidelines on good pharmacy practice: standards for quality of pharmacy services. WHO Technical Report Series, 2011; Available from: http://apps.who.int/ medicinedocs/documents/s18676en/s18676en.pdf.

Bureau of Drug Control. Statistic of drugstore license in Thailand from 1996 – 2013; Available from: http://drug.fda.moph.go.th/zone _search/sea001.asp.

P. Plianbangchang, S. Junpratat, and T. Thongphoem. Steroid tablet inappropriate selling behavior among drug stores in Muang District, Phitsanulok, JHS. 10(4): 594-601 (2001).

P. Kaewon, S. Lerkiatbundit, and W. Saengcharoen. Is there any difference in the quality between the pharmacies accredited by the pharmacy council and non-accredited pharmacies? TJPP. 4(2): 39-64 (2012).

S. Niyomdacha and S. Lerkiatbundit. Barriers in law enforcement for pharmaciests' license hanging: case study of the provincial public health offices in the South, TJPP. 5(2): 131-149 (2013).

N. Cheewasrirungrueng, S. Lerkiatbundit, and S. Soorapan. Drug related problems due to incomplete history taking in community pharmacies: cases of purchasing drugs for others and demanding for specific drugs, TJPP, 2(1): 60-75 (2010).

The Office of Pharmacy Advancement Project. Background of community pharmacy accreditation. Available from: http://newsser.fda. moph.go.th/advancepharmacy/2009/index.php.

P . Puntaluck. Understanding decision of pharmacy-owning pharmacists to enroll in the community pharmacy accreditation program in Nakhornatchasima province [dissertation]. Faculty of Pharmaceutical Science, Bangkok (BKK): Chulalongkorn University; 2008.

H. S. Krishnan and M. Schaefer. Evaluation of the impact of pharmacists' advice giving on the outcomes of self-medication in patients suffering from dyspepsia, Pharm. World Sci. 22(3): 102-108 (2000).

L. Roughead, S. Semple, and A. Vitry. The value of pharmacist professional services in the community setting: a systematic review of the literature 1990-2002, Quality Use of Medicines and Pharmacy Research Centre, University of South Australia, South Australia, 2005. [11] Bureau of Drug Control. Good Pharmacy Practice for FDA officer. Available from: http://drug.fda.moph.go.th/zone_service/ser061 .asp.

Organization for Economic Co-operation and Development. Introductory handbook for undertaking regulatory impact analysis (RIA), 2008.

S. Vimolkittipong. Possibility of drugstore to comply with the Ministry of Public Health notification on Good Pharmacy Practice regulation, Thai Food and Drug Administration: Bureau of Drug Control, 2012.

National Statistical Office, Ministry of Information and Communication Technology. The 2012 household socio-economic survey, 2012; Available from: http://service.nso.go.th/nso/nsopublish /themes/files/SociosumRep55.pdf.

J. A. Johnson and J. L. Bootman. Drug-related morbidity and mortality: a cost-of-illness model, Arch. Intern. Med. 155 (18): 1949- 1956 (1995).

F. R. Ernst and A. J. Grizzle. Drug-related morbidity and mortality: updating the cost-of-illness model, J. Am. Pharm. Assoc. (Wash). 41(2): 192-199 (2001).

K. J. Patel, M. S. Kedia, D. Bajpai, S. S. Mehta, N. A. Kshirsagar, and N. J. Gogtay. Evaluation of the prevalence and economic burden of adverse drug reactions presenting to the medical emergency department of a tertiary referral centre: a prospective study, BMC Clin. Pharmacol. 7(8): 1-5 (2007).

S. Pattanaik, P. Dhamija, S. Malhotra, N. Sharma, and P. Pandhi. Evaluation of cost of treatment of drug-related events in a tertiary care public sector hospital in Northern India: a prospective study, Br. J. Clin. Pharmacol. 67(3): 363-369 (2009).

C. Siltharm and M. Thavorncharoensap. Cost of Adverse Drug Reactions (ADRs) induced hospitalization: a systematic review, MUJPS. 40(4): 40-49 (2013).

S. Saokaew, S. Maphanta, and P. Thangsomboon. Impact of pharmacist's interventions on cost of drug therapy in intensive care unit, Pharm. Pract. (Granada). 7(2): p. 81-87 (2009).

Department of Provincial Administration. Thai population as of 31 December 2013. 2013 [cited 2014 6 December]; Available from: http://stat.bora.dopa.go.th/stat/y_stat56.html.

D. A. Sclar, L. M. Robison, and T. L. Skaer. Pharmacy consultation and over-the-counter medication purchasing outcomes, J. Clin. Pharm. Ther. 21(3): 177-184 (1996).

A. C. Dreyer. Research into aspects of pharmacists service, SAPJ. 62: 196 (1995).

A. C. Dreyer, J. H. Serfontein, H. L. Van DerMeer, and S. Wagner. Cost savings effected by community pharmacists' interventions in the supply of medicines in the Republic of South Africa. J. Res. Pharmaceut. Econ. 9(4): 1-20 (1999).

Thai Food and Drug Administration. Annual financial report for subdivision activities 2012, 2012: Thai Food and Drug Administration. [26] Tonchabub Company. All kinds of printing services, Offset Printing. [cited 2014 December 8]; Available from: http://www. tonchabub.co.th/en.

OfficeMate. [cited 2014 December 5]; Available from: http://www.officemate.co.th/.

T. Chompoo. Economic evaluation to participate in an accredited pharmacy in Chiang Mai, Faculty of Economics, Chiang Mai University; 2010.

The Pharmacy Council of Thailand. [cited 2014 December 5]; Available from: http://www.pharmacycouncil.org/index.php?option= content_detail&menuid=0&itemid=445.

SmartDrugstore: Drugstore Management System. [cited 2014; Available from: http://www.software.worldmedic.com/dms/main/index. php.

Company, K. Kanpim.com. [cited 2014 December 5]; Available from: http://www.kanpim.com/?P=101.

S. Ngosurachet, P . Phromiat, W. Chairitthiphong, A. Saranopphakhunna, H. Yihama, and K. Chaiyakan. 2012 Pharmacist Compensation Survey in Thailand, TJPP. 5(2): 121-130 (2013).

Kelly Services. Kelly Services Thailand: 2013/14 Salary Guide, 2013 [cited 2014 December 9]; Available from: http://www. kellyservices.co.th/uploadedFiles/Thailand_Kelly_Services/4-Resource Center/White_Papers_and_Reports/Thailand%20Salary% 20ebook%202013-14.pdf.

N. Sumpradit, P. Chongtrakul, K. Anuwong, S. Pumtong, K. Kongsomboon, P. Butdeemee, J. Khonglormyati, S. Chomyong, P. Tongyoung, S. Losiriwat, P. Seesuk, P. Suwanwaree, and V. Tangcharoensathien. Antibiotics Smart Use: a workable model for promoting the raional use of medicines in Thailand, Bull. World Health Organ. 90(12): 905-913 (2012).

T. Uaviseswong, U. Chaikledkaew, and P. Tragulpiankit. Systematic review of economic evaluation of pharmacist intervention related to adverse drug event prevention among patients with hospitalization. MUJPS. 39(1): 38-43 (2012).

K. L. Rascati. Essentials of pharmacoeconomics. 2nd ed, Philadelphia, Wolters Kluwer/Lippincott Williams & Wilkins, 2009. [37] Trading Economics. Thailand inflation rate 1977-2014. [cited 2014 December 26]; Available from: http://www.tradingeconomics.com/ thailand/inflation-cpi.


Refbacks

  • There are currently no refbacks.